Biopharmaceuticals
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
Aim & Scope
This section is dedicated to research on the therapeutic, diagnostic, prognostic and immunoprophylactic developments of important biological macromolecules built from amino acids, sugars, nucleic acids, comprising small basic units of which they are composed, and mimetics produced by chemical synthesis. Contributions focusing on biopharmaceutical applications of more complex entities, such as phages, viruses, exosomes and stem cells, among others, are also welcome. Also reports on structure and molecular interactions determinant for biopharmaceuticals bioactivity or pharmaceutical applications, e.g. by computational and NMR studies are also accepted.
Keywords
- Peptides
- Proteins
- RNA
- DNA
- Nucleic Acids
- Aptamers
- Carbohydrates
- Glycans
- Polysaccharides
- Macromolecules
- Chemical Synthesis
- Ribonucleoproteins
- Antibodies
- Phages
- Viruses
- Therapeutic Tools
- Peptidomimetics
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Strategies for Improving Peptide Stability and Delivery (Deadline: 20 October 2023)
- Polysaccharides as Drug Candidates (Deadline: 30 October 2023)
- Structural and Other Proteomics Approaches in Drug Discovery (Deadline: 31 October 2023)
- Novel Applications of Natural Polysaccharides for Pharmaceuticals (Deadline: 30 November 2023)
- New Endogenous Opioid Peptides and Peptidomimetics with Potential Biological Importance (Deadline: 30 November 2023)
- Recent Advances of Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (Deadline: 30 November 2023)
- Design, Synthesis, and Evaluation of Nucleobase, Nucleoside, and Nucleotide Analogues (Deadline: 15 December 2023)
- Inflammasomes as the Target of Pharmacotherapy (Deadline: 20 December 2023)
- Cardiovascular Diseases: Where Do We Stand with Human-Derived Stem Cells? (Deadline: 22 December 2023)
- Antimicrobial Peptides and Proteins: A Potential Approach to Treat and Combat Antimicrobial Resistance (Deadline: 22 December 2023)
- Phage Discovery and Phage Therapy (Deadline: 22 December 2023)
- Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Inhibitors in Health and Disease (Deadline: 23 December 2023)
- Cell Fate Manipulation for Bone and Cartilage Reconstruction (Deadline: 28 December 2023)
- Naturally-Occurring Peptides and Proteins as Leads for Drug Discovery and Development (Deadline: 29 December 2023)
- The 20th Anniversary of Pharmaceuticals – the Application of Adjuvants and Nanomaterials in Antimicrobial Intervention (Deadline: 31 December 2023)
- HIV and Viral Hepatitis: Prevention, Treatment and Coinfection (Deadline: 20 January 2024)
- New Advances in Mesenchymal Stromal Cells as Therapeutic Tools (Deadline: 22 January 2024)
- Cystic Fibrosis and Rare Mutations: New Promising Approaches via Proteostase Modulators (Deadline: 16 February 2024)
- Stem Cell as Tool for Drug Development (Deadline: 29 February 2024)
- The 20th Anniversary of Pharmaceuticals: Advances in Peptide Drug Design and Development: From Sequences to Drug Candidates (Deadline: 20 March 2024)
- Stem Cells and Organoids as Tools for Drug Development (Deadline: 31 March 2024)
- Novel Vaccine Adjuvants (Deadline: 31 March 2024)
- Antivirals and Targets to Fight RNA Viruses (Deadline: 31 March 2024)
- Antimicrobial Peptides: Design, Synthesis and Pharmaceutical Applications (Deadline: 20 June 2024)
- Glycans and Glycan-Binding Proteins in Drug Research (Deadline: 28 June 2024)
- Pluripotent Stem Cell for Novel Drug Discovery (Deadline: 30 June 2024)
- The 20th Anniversary of Pharmaceuticals—Emerging Trends in Biopharmaceuticals (Deadline: 30 June 2024)
- Organ Regeneration by Application of Biomaterials and Stem Cells Technology Tools (Deadline: 12 July 2025)
